Guardian Pharmacy Services, Inc. is a prominent provider of specialized pharmacy solutions dedicated to the long-term care sector, catering to assisted living and skilled nursing facilities. The company is renowned for its personalized medication management, stringent quality and compliance standards, and exceptional customer service. Leveraging advanced technology and extensive pharmaceutical expertise, Guardian enhances patient outcomes while optimizing operational efficiency for healthcare partners. With a significant operational footprint across various states, the company is strategically positioned to meet the increasing demand for customized pharmacy services in a dynamic healthcare landscape.
| Revenue (TTM) | $1.46B |
| Gross Profit (TTM) | $304.68M |
| EBITDA | $110.91M |
| Operating Margin | 6.20% |
| Return on Equity | 26.90% |
| Return on Assets | 14.40% |
| Revenue/Share (TTM) | $23.22 |
| Book Value | $3.49 |
| Price-to-Book | 12.04 |
| Price-to-Sales (TTM) | 1.74 |
| EV/Revenue | 1.807 |
| EV/EBITDA | 25.72 |
| Quarterly Earnings Growth (YoY) | 39.00% |
| Quarterly Revenue Growth (YoY) | 2.20% |
| Shares Outstanding | $49.78M |
| Float | $31.99M |
| % Insiders | 37.52% |
| % Institutions | 58.24% |
Volatility is currently expanding
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Wellness Concepts, a long-term care pharmacy based in Grottoes, Virginia.
Do you have more faith in DuPont analysis than in simple ROE calculation? Tap CASY, ECG, GRDN, EXPD and MAMA for gains.
Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since 2004, has decided to retire, effective as of July 1, 2026. Upon Mr. Forbes's retirement, David Morris, currently Executive Vice President and Chief Financial Officer of Guardian will assume the role of Chief Operating Officer. In connection with Mr. Morris' new role, Will Mudd, Senior Vice President, Finance, has b.
Guardian Pharmacy (GRDN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Guardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.21 per share a year ago.
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Guardian Pharmacy (GRDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release first quarter 2026 financial results after market close on Wednesday, May 6, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (833) 461-5787 for participants located in the United Sta.
